Last reviewed · How we verify
paroxetine, duloxetine, fluoxetine or venlafaxine
paroxetine, duloxetine, fluoxetine or venlafaxine is a Small molecule drug developed by prof. Peter de Jonge. It is currently in Phase 2 development. Also known as: Paxil, Cymbalta, Prozac, Effexor.
At a glance
| Generic name | paroxetine, duloxetine, fluoxetine or venlafaxine |
|---|---|
| Also known as | Paxil, Cymbalta, Prozac, Effexor |
| Sponsor | prof. Peter de Jonge |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Neurobiological and Genomic Predictors of Relapse in Depression
- Efficacy of Chronotherapeutic Combination for Major Depressive Episode With Insomnia (PHASE3)
- Effect of Exercise on Tapering Antipsychotics in Patients With Psycho-cardiological Disease(EXTRA-study) (NA)
- A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy (PHASE2)
- eIMPACT-DM Pilot Trial: Depression Treatment to Reduce Diabetes Risk (PHASE2)
- A Trial to Evaluate the Efficacy, Safety & Tolerability of Brexpiprazole in the Maintenance Treatment of Adults With Major Depressive Disorder (PHASE3)
- Multimodal Magnetic Resonance Imaging-based Study of Electroconvulsive Efficacy Prediction in Adolescents With Depression: a Multicenter Prospective Cohort Study
- Adjunctive Mixed Salts Amphetamine for Depressed Adults With Incomplete Response to Current Antidepressant Therapy (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- paroxetine, duloxetine, fluoxetine or venlafaxine CI brief — competitive landscape report
- paroxetine, duloxetine, fluoxetine or venlafaxine updates RSS · CI watch RSS
- prof. Peter de Jonge portfolio CI
Frequently asked questions about paroxetine, duloxetine, fluoxetine or venlafaxine
What is paroxetine, duloxetine, fluoxetine or venlafaxine?
paroxetine, duloxetine, fluoxetine or venlafaxine is a Small molecule drug developed by prof. Peter de Jonge.
Who makes paroxetine, duloxetine, fluoxetine or venlafaxine?
paroxetine, duloxetine, fluoxetine or venlafaxine is developed by prof. Peter de Jonge (see full prof. Peter de Jonge pipeline at /company/prof-peter-de-jonge).
Is paroxetine, duloxetine, fluoxetine or venlafaxine also known as anything else?
paroxetine, duloxetine, fluoxetine or venlafaxine is also known as Paxil, Cymbalta, Prozac, Effexor.
What development phase is paroxetine, duloxetine, fluoxetine or venlafaxine in?
paroxetine, duloxetine, fluoxetine or venlafaxine is in Phase 2.
Related
- Manufacturer: prof. Peter de Jonge — full pipeline
- Also known as: Paxil, Cymbalta, Prozac, Effexor
- Compare: paroxetine, duloxetine, fluoxetine or venlafaxine vs similar drugs
- Pricing: paroxetine, duloxetine, fluoxetine or venlafaxine cost, discount & access